Skip to main content
News Tag: Newsletter
Assessing Adaptive Radiotherapy and Chemotherapy for Muscle-Invasive Bladder Cancer (NRG-GU015, The ARCHER Trial)
Read More
Advocate Angle: How biobanking can empower a cancer patient
Read More
Reena Cecchini, PhD, Promoted to Research Associate Professor at the University of Pittsburgh
Read More
Testing Immunotherapy with Radiation Therapy for Patients with High-Risk, T1 Bladder Cancer (NRG-GU014, The PARRC Trial)
Read More
In Memoriam – Victor G. Vogel, MD, MHS, FACP
Read More
NRG-GY037 Aims to Advance Outcomes in High-Risk Cervical Cancer
Read More
PSC Column: Record Retention in Clinical Trials. . . . Where are they now?
Read More
FORTE – New Enrollment Record!
Read More
FORTE Study Updates: September 2025
Read More
PSC: Short Form Consent: The Who, What, When, Where, Why & How’s
Read More